Question 1

Does Price T Rowe Associates own PRAX stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Price T Rowe Associates holds 942,999 shares of PRAX (Praxis Precision Medicines), worth $315.7M.

Question 2

How many shares of PRAX does Price T Rowe Associates own?

Accepted Answer

As of its Q2 2026 13F, Price T Rowe Associates holds 942,999 shares of PRAX (Praxis Precision Medicines).

Question 3

What is Price T Rowe Associates' PRAX position worth?

Accepted Answer

As of its Q2 2026 13F, Price T Rowe Associates' PRAX position is worth $315.7M.

Question 4

Is Price T Rowe Associates buying or selling PRAX?

Accepted Answer

In Q2 2026, Price T Rowe Associates increased its PRAX position by 312,147 shares (+49.5%).

Question 5

When did Price T Rowe Associates first buy PRAX?

Accepted Answer

Price T Rowe Associates first reported PRAX in its Q1 2024 13F and has listed it in 10 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	942,999	+49.5%	$315.7M	0.0%	$334.79	43
2026-Q1	Decreased	630,852	-19.7%	$203.3M	0.0%	$318.22	0
2025-Q4	Decreased	785,987	-21.7%	$231.7M	0.0%	$297.02	0
2025-Q3	Decreased	1M	-31.9%	$53.2M	0.0%	$52.38	0
2025-Q2	Increased	1.5M	+34.4%	$61.9M	0.0%	$43.00	38
2025-Q1	Decreased	1.1M	-9.3%	$41.5M	0.0%	$38.66	0
2024-Q4	Increased	1.2M	+7.9%	$93M	0.0%	$76.26	32
2024-Q3	Increased	1.1M	+19.3%	$64.5M	0.0%	$57.83	35